Soliris May Be Safe, Effective for Rituximab-refractory gMG

Soliris May Be Safe, Effective for Rituximab-refractory gMG

309592

Soliris May Be Safe, Effective for Rituximab-refractory gMG

Soliris (eculizumab) appears to be safe and effective for patients with hard-to-treat generalized myasthenia gravis (gMG) who have acetylcholine receptor (AChR) antibodies, a study has found. Its benefits were extended to a particular group of patients from the Phase 3 REGAIN clinical trial and its extension study who were treated previously with — but did not respond, or were refractory to — rituximab. The findings suggest that Soliris may work for patients with gMG “irrespective of their…

You must be logged in to read/download the full post.